Literature DB >> 28417336

Treatment of Depression in Adults with Fabry Disease.

Nadia Ali1, Scott Gillespie2, Dawn Laney3.   

Abstract

Fabry disease (FD) is a genetic X-linked, multisystemic, progressive lysosomal storage disorder (LSD). Depression has emerged as a disease complication, with prevalence estimates ranging from 15 to 62%. This is a pilot study examining the effects of psychological counseling for depression in FD on depression, adaptive functioning (AF), quality of life (QOL), and subjective pain experience. Telecounseling was also piloted, as it has beneficial effects in other chronic diseases which make in-person counseling problematic. Subjects completed 6 months of in-person or telecounseling with the same health psychologist, followed by 6 months without counseling. Self-report measures of depression, AF, QOL, and subjective pain were completed every 3 months. All subjects experienced improvements in depression, which were sustained during the follow-up period. Improvements in depression were correlated with improvements in mental health QOL and subjective pain severity, while improvements in mental health QOL were correlated with improvements in AF. While statistical comparison between counseling modes was not possible with the given sample size, relevant observations were noted. Recommendations for future research include replication of results with a larger sample size and a longer counseling period. The use of video counseling may be beneficial. In conclusion, the present pilot study supports the efficacy of psychological treatment for depression in people with FD, highlighting the importance of having health psychologists housed in LSD treatment centers, rather than specialty psychology/psychiatry settings, to increase participation and decrease potential obstacles to access due to perceived stigma.

Entities:  

Keywords:  Adaptive functioning; Depression; Fabry; Quality of life; Telecounseling

Year:  2017        PMID: 28417336      PMCID: PMC5874216          DOI: 10.1007/8904_2017_21

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  42 in total

1.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females.

Authors:  K D MacDermot; A Holmes; A H Miners
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

Review 2.  Impact of major depression on chronic medical illness.

Authors:  Wayne Katon; Paul Ciechanowski
Journal:  J Psychosom Res       Date:  2002-10       Impact factor: 3.006

3.  Therapeutic alliance in face-to-face and telephone-administered cognitive behavioral therapy.

Authors:  Colleen Stiles-Shields; Mary J Kwasny; Xuan Cai; David C Mohr
Journal:  J Consult Clin Psychol       Date:  2014-01-20

4.  Telephone-administered psychotherapy for depression.

Authors:  David C Mohr; Stacey L Hart; Laura Julian; Claudine Catledge; Lara Honos-Webb; Lea Vella; Edwin T Tasch
Journal:  Arch Gen Psychiatry       Date:  2005-09

5.  Psychological health in adults with morquio syndrome.

Authors:  Nadia Ali; S Cagle
Journal:  JIMD Rep       Date:  2015-01-23

6.  Telephone interpersonal counseling with women with breast cancer: symptom management and quality of life.

Authors:  Terry Badger; Chris Segrin; Paula Meek; Ana Maria Lopez; Elizabeth Bonham; Amelia Sieger
Journal:  Oncol Nurs Forum       Date:  2005-03-05       Impact factor: 2.172

7.  Social-adaptive and psychological functioning of patients affected by Fabry disease.

Authors:  Dawn Alyssia Laney; Daniel J Gruskin; Paul M Fernhoff; Joseph F Cubells; Opal Y Ousley; Heather Hipp; Ami J Mehta
Journal:  J Inherit Metab Dis       Date:  2010-01-20       Impact factor: 4.982

Review 8.  The effectiveness of telemental health: a 2013 review.

Authors:  Donald M Hilty; Daphne C Ferrer; Michelle Burke Parish; Barb Johnston; Edward J Callahan; Peter M Yellowlees
Journal:  Telemed J E Health       Date:  2013-06       Impact factor: 3.536

Review 9.  Cognitive dysfunction and depression in Fabry disease: a systematic review.

Authors:  Fay E Bolsover; Elaine Murphy; Lisa Cipolotti; David J Werring; Robin H Lachmann
Journal:  J Inherit Metab Dis       Date:  2013-08-16       Impact factor: 4.982

10.  Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry.

Authors:  Torquil Watt; Alessandro P Burlina; Chiara Cazzorla; Dorothee Schönfeld; Maryam Banikazemi; Robert J Hopkin; Ana Maria Martins; Katherine Sims; Dana Beitner-Johnson; Fanny O'Brien; Ulla Feldt-Rasmussen
Journal:  Genet Med       Date:  2010-11       Impact factor: 8.822

View more
  7 in total

1.  Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry disease.

Authors:  Simon Körver; Gert J Geurtsen; Carla E M Hollak; Ivo N van Schaik; Maria G F Longo; Marjana R Lima; Leonardo Vedolin; Marcel G W Dijkgraaf; Mirjam Langeveld
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

2.  Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and pain.

Authors:  Simon Körver; Gert J Geurtsen; Carla E M Hollak; Ivo N van Schaik; Maria G F Longo; Marjana R Lima; Leonardo Vedolin; Marcel G W Dijkgraaf; Mirjam Langeveld
Journal:  Orphanet J Rare Dis       Date:  2020-01-28       Impact factor: 4.123

3.  Depression, sleep disturbances, pain, disability and quality of LIFE in Brazilian Fabry disease patients.

Authors:  Nilton Salles Rosa Neto; Judith Campos de Barros Bento; Rosa Maria Rodrigues Pereira
Journal:  Mol Genet Metab Rep       Date:  2019-12-02

4.  Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy.

Authors:  Marina Dutra-Clarke; Daisy Tapia; Emily Curtin; Dennis Rünger; Grace K Lee; Anita Lakatos; Zyza Alandy-Dy; Linda Freedkin; Kathy Hall; Nesrin Ercelen; Jousef Alandy-Dy; Margaret Knight; Madeleine Pahl; Dawn Lombardo; Virginia Kimonis
Journal:  Mol Genet Metab Rep       Date:  2020-12-31

5.  Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic Review.

Authors:  Magdalena Mroczek; Ignazio Maniscalco; Manon Sendel; Ralf Baron; Erich Seifritz; Albina Nowak
Journal:  Front Psychiatry       Date:  2022-03-16       Impact factor: 4.157

6.  Quality of life in patients with Fabry's disease: a cross-sectional study of 86 adults.

Authors:  Caroline Andonian; Jürgen Beckmann; Oliver Mayer; Peter Ewert; Annika Freiberger; Maximilian Huber; Harald Kaemmerer; Christine Kurschat; Florian Lagler; Nicole Nagdyman; Lars Pieper; Claudia Regenbogen; Sebastian Freilinger
Journal:  Cardiovasc Diagn Ther       Date:  2022-08

7.  Cognitive functioning and depressive symptoms in Fabry disease: A follow-up study.

Authors:  Simon Körver; Gert J Geurtsen; Carla E M Hollak; Ivo N van Schaik; Maria G F Longo; Marjana R Lima; Marcel G W Dijkgraaf; Mirjam Langeveld
Journal:  J Inherit Metab Dis       Date:  2020-06-25       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.